Considering that Burkitt’s lymphoma (BL) continues to be a challenging hematological malignancy, we investigated whether the synergy of HSP90 and CIK cells could pave the way for a potential treatment. This evidence concerns the gene HSP90AA1 and Burkitt lymphoma.